Agmatine attenuates acquisition but not the expression of ethanol conditioned place preference in mice: A role for imidazoline receptors

Behavioural Pharmacology

Volumn 24, Issue 2, 2013, Pages 87-94

  Sameer, Shaikh M ^a   Chakraborty, Suwarna S ^a   Ugale, Rajesh R ^a,b  

^a New Kamptee   (India)

^b GURU GHASIDAS UNIVERSITY   (India)

Author keywords

agmatine; conditioned place preference; ethanol dependence; imidazoline I 1 or I2 receptors; rat

Indexed keywords

2 (2 IMIDAZOLIN 2 YL)QUINOLINE; AGMATINE; ALCOHOL; EFAROXAN; IMIDAZOLINE RECEPTOR; MOXONIDINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; ATTENUATION; AVERSION; CONDITIONING; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; LOCOMOTION; MALE; MODULATION; MOUSE; NONHUMAN; PLACE PREFERENCE;

AGMATINE; ALCOHOL DETERRENTS; ALCOHOLISM; ANIMALS; ANTI-ANXIETY AGENTS; BEHAVIOR, ADDICTIVE; BEHAVIOR, ANIMAL; CONDITIONING, CLASSICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; IMIDAZOLINE RECEPTORS; INJECTIONS, INTRAPERITONEAL; MALE; MICE; MOLECULAR TARGETED THERAPY; MONOAMINE OXIDASE; MONOAMINE OXIDASE INHIBITORS; MOTOR ACTIVITY; NEUROTRANSMITTER AGENTS;

EID: 84874938252     PISSN: 09558810     EISSN: 14735849     Source Type: Journal    
DOI: 10.1097/FBP.0b013e32835efc46     Document Type: Article

References (46)

1. Adams ML, Sewing BN, Chen J, Meyer ER, Cicero TJ (1995). Nitric oxide-related agents alter alcohol withdrawal in male rats. Alcohol Clin Exp Res 19: 195-199.
2. Carboni E, Silvagni A, Rolando MT, Di Chiara G (2000). Stimulation of in vivo dopamine transmission in the bed nucleus of stria terminalis by reinforcing drugs. J Neurosci 20:1-5.
3. Diamant S, Eldar-Geva T, Atlas D (1992). Imidazoline binding sites inhuman placenta: evidence for the heterogeneity and a search for physiological function. Br J Pharmacol 106:101-108.
4. Do Couto BR, Aguilar MA, Rodriguez-Arias M, Minarro J (2005). Long-lasting rewarding effects of morphine induced by drug primings. Brain Res 1050:53-63.
5. Eglen RM, Hudson AL, Kendall DA, Nutt DJ, Morgan NG, Wilson VG, Dillon MP (1998). 'Seeing through a glass darkly': casting light on imidazoline 'I' sites. Trends Pharmacol Sci 19:381-390.
6. Galea E, Regunathan S, Eliopoulos V, Feinstein DL, Reis DJ (1996). Inhibition of mammalian nitric oxide synthases by agmatine, an endogenous polyamine formed by decarboxylation of arginine. Biochem J 316:247-249.
7. Georges F, Aston-Jones G (2003). Prolonged activation of mesolimbic dopaminergic neurons by morphine withdrawal following clonidine: participation of imidazoline and norepinephrine receptors. Neuropsychopharmacology 28:1140-1149.
8. Gibson DA, Harris BR, Rogers DT, Littleton JM (2002). Radioligand binding studies reveal agmatine is a more selective antagonist for a polyamine-site on the NMDA receptor than arcaine or ifenprodil. Brain Res 952:71-77.
9. Gong ZH, Li YF, Zhao N, Yang HJ, Su RB, Luo ZP, et al. (2006). Anxiolytic effect of agmatine in rats and mice. Eur J Pharmacol 550:112-116.
10. Koob GF, Roberts AJ, Schulteis G, Parsons LH, Heyser CJ, Hyytia P (1998). Neurocircuitry targets in ethanol reward and dependence. Alcohol Clin Exp Res 22:3-9.
11. 2-adrenoceptors. Behav Brain Res 213:161-174.
12. Krass M, Wegener G, Vasar E, Volke V (2008). Antidepressant-like effect of agmatine is not mediated by serotonin. Behav Brain Res 188:324-328.
13. LaLumiere RT, Kalivas PW (2008). Glutamate release in the nucleus accumbens core is necessary for heroin seeking. J Neurosci 28:3170-3177.
14. Lewis B, Wellmann KA, Barron S (2007). Agmatine reduces balance deficits in a rat model of third trimester binge-like ethanol exposure. Pharmacol Biochem Behav 88:114-121.
15. 2 receptors: target for new analgesics? Eur J Pharmacol 658:49-56.
16. 2-site-specific ligands and monoamine oxidase inhibitors in rats with a unilateral 6-hydroxydopamine lesion of the nigrostriatal pathway. Br J Pharmacol 143:952-959.
17. 2-site ligands, MAOIs, b-carbolines, agmatine and ibogaine. Br J Pharmacol 135: 1227-1234.
18. Maldonado R (1997). Participation of noradrenergic pathways in the expression of opiate withdrawal. Biochemical and pharmacological evidence. Neurosci Biobehav Rev 21:91-104.
19. Morgan AD, Campbell UC, Fons RD, Carroll ME (2002). Effects of agmatine on the escalation of intravenous cocaine and fentanyl self-administration in rats. Pharmacol Biochem Behav 72:873-880.
20. Ortiz J, Fitzgerald LW, Charlton M, Lane S, Trevisan L, Guitart X, et al. (1995). Biochemical actions of chronic ethanol exposure in the mesolimbic dopamine system. Synapse 21:289-298.
21. Otake K, Ruggiero DA, Regunathan S, Wang H, Milner TA, Reis DJ (1998). Regional localization of agmatine in the rat brain: an immuno-cytochemical study. Brain Res 787:1-14.
22. Ozden O, Kayir H, Ozturk Y, Uzbay T (2011). Agmatine blocks ethanol-induced locomotor hyperactivity in male mice. Eur J Pharmacol 659:26-29.
23. Reis DJ, Regunathan S (1999). Agmatine: an endogenous ligand at imidazoline receptors is a novel neurotransmitter. Ann N Y Acad Sci 881:65-80.
24. Reis DJ, Regunathan S (2000). Is agmatine a novel neurotransmitter in brain? Trends Pharmacol Sci 21:187-193.
25. Risinger FO, Boyce JM (2002). 5-HT1A receptor blockade and the motivational profile of ethanol. Life Sci 28:707-715.
26. Ruggiero DA, Regunathan S, Wang H, Milner T, Reis DJ (1998). Immunocyto-chemical localization of an imidazoline receptor protein in the central nervous system. Brain Res 780:270-293.
27. Su RB, Wei XL, Zheng JQ, Liu Y, Lu XQ, Li J (2004). Anticonvulsive effect of agmatine in mice. Pharmacol Biochem Behav 77:345-349.
28. Su RB, Lu XQ, Huang Y, Liu Y, Gong ZH, Wei XL, et al. (2008a). Effects of intragastric agmatine on morphine-induced physiological dependence in beagle dogs and rhesus monkeys. Eur J Pharmacol 587:155-162.
29. Su RB, Ren YH, Liu Y, Ding T, Lu XQ, Wu N, et al. (2008b). Agmatine inhibits morphine-induced drug discrimination in rats. Eur J Pharmacol 593:62-67.
30. Sugawara AM, Miguel TT, Pereira DT, Menani JV, De Luca LA Jr. (2001). Effect of central imidazolinergic and alpha 2-adrenergic activation on water intake. Braz J Med Biol Res 34:185-190.
31. Tahsili-Fahadan P, Yahyavi-Firouz-Abadi N, Khoshnoodi MA, Motiei-Langroudi R, Tahaei SA, Ghahremani MH, et al. (2006). Agmatine potentiates morphi-neinduced conditioned place preference in mice: modulation by alpha(2)-adrenoceptors. Neuropsychopharmacology 31:1722-1732.
32. Taksande BG, Kotagale NR, Patel MR, Shelkar GP, Ugale RR, Chopde CT (2010). Agmatine, an endogenous imidazoline receptor ligand modulates ethanol anxiolysis and withdrawal anxiety in rats. Eur J Pharmacol 637: 89-101.
33. Thorn DA, Winter JC, Li JX (2012). Agmatine attenuates methamphetamine-induced conditioned place preference in rats. Eur J Pharmacol 680:69-72.
34. Uzbay TI (2012). The pharmacological importance of agmatine in the brain. Neurosci Biobehav Rev 36:502-519.
35. Uzbay IT, Erden BF, Tapanyigit EE, Kayaalp SO (1997). Nitric oxide synthase inhibition attenuates signs of ethanol withdrawal in rats. Life Sci 61:2197-2209.
36. Uzbay IT, Yesilyurt O, Celik T, Ergun H, Isimer A (2000). Effect of agmatine on ethanol withdrawal syndrome in rats. Behav Brain Res 107:153-159.
37. Wade CL, Schuster DJ, Domingo KM, Kitto KF, Fairbanks CA (2008). Supraspinally administered agmatine attenuates the development of oral fentanyl self-administration. Eur J Pharmacol 587:135-140.
38. Wang XF, Wu N, Su RB, Lu XQ, Liu Y, Li J (2011). Agmatine modulates neuroadaptations of glutamate transmission in the nucleus accumbens of repeated morphine-treated rats. Eur J Pharmacol 650:200-205.
39. Wei XL, Su RB, Lu XQ, Liu Y, Yu SZ, Yuan BL, et al. (2005). Inhibition by agmatine on morphine-induced conditioned place preference in rats. Eur J pharmacol 515:99-106.
40. Wei XL, Su RB, Wu N, Lu XQ, Zheng JQ, Li J (2007). Agmatine inhibits morphine induced locomotion sensitization and morphine-induced changes in striatal dopamine and metabolites in rats. Eur Neuropsychopharmacol 17:790-799.
41. Weiss F, Lorang MT, Bloom FE, Koob GF (1993). Oral alcohol self-administration stimulates dopamine release in the rat nucleus accumbens: genetic and motivational determinants. J Pharmacol Exp Ther 267:250-258.
42. Wellmann K, Lewis B, Barron S (2010). Agmatine reduces ultrasonic vocalization deficits in female rat pups exposed neonatally to ethanol. Neurotoxicol Teratol 32:158-163.
43. 1 receptor. Eur J Pharmacol 548:21-28.
44. Yananli H, Goren MZ, Berkman K, Aricioglu F (2007). Effect of agmatine on brain L-citrulline production during morphine withdrawal in rats: a microdialysis study in nucleus accumbens. Brain Res 1132:51-58.
45. 2-adrenoceptor-mediated mechanism in mice. Neuropsy-chopharmacology 25:98-103.
46. Zaniewska M, McCreary AC, Sezer G, Przegalinski E, Filip M (2008). Effects of agmatine on nicotine-evoked behavioral responses in rats. Pharmacol Rep 60:645-654.